These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15477792)
1. [Effects of lisinopril on platelet aggregation in patients with arterial hypertension with metabolic syndrome]. Medvedev IN; Gromnatskiĭ NI; Golikov BM; Al'-Zuraĭki EM; Li VIu Kardiologiia; 2004; 44(10):57-9. PubMed ID: 15477792 [No Abstract] [Full Text] [Related]
2. [Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension]. Britov AN; Alamdarova II; Deev AD; Orlov AA Kardiologiia; 2003; 43(10):66-71. PubMed ID: 14748343 [No Abstract] [Full Text] [Related]
3. [Effect of enalapril, lisinopril, and amlodipine on the course of chronic gastrititis in patients with arterial hypertension]. Alekseenko SA; Timoshin SS; Avilova AA; Fleĭshman MIu; Lamekhova VG Klin Med (Mosk); 2004; 82(9):42-5. PubMed ID: 15540422 [TBL] [Abstract][Full Text] [Related]
4. [The influence of antihypertensive agents on plasmatic and vascular-thrombocytic homeostasis in metabolic syndrome]. Vengerovskiĭ AI; Idrisova EM; Bushkova EA; Mananko EI; Krasnova NM Eksp Klin Farmakol; 2008; 71(6):8-12. PubMed ID: 19140507 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of antihypertensive efficacy of moexipril in metabolic syndrome]. Ivleva AIa; Moskvicheva IuB; Poluianova NV; Minina ES; Kolesnikova AV Kardiologiia; 2005; 45(12):35-9. PubMed ID: 16353045 [No Abstract] [Full Text] [Related]
6. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease]. Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414 [TBL] [Abstract][Full Text] [Related]
7. [Effect of amlodipine on intravascular thrombocyte activity in patients with arterial hypertension and metabolic syndrome]. Medvedev IN; Gromnatskiĭ NI Klin Med (Mosk); 2005; 83(2):37-40. PubMed ID: 15803830 [TBL] [Abstract][Full Text] [Related]
8. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations? Hilgers KF; Mann JF Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734 [No Abstract] [Full Text] [Related]
9. The effects of lisinopril and nifedipine on parotid function: two case reports. Streckfus CF; Welsh S; Jenkins P; Brown R; Miller V MSDA J; 1992; 35(4):11-4. PubMed ID: 9552628 [No Abstract] [Full Text] [Related]
10. [Normodipin in correction of platelet rheology in hypertensive patients with metabolic syndrome]. Medvedev IN; Gromnatskiĭ NI Ter Arkh; 2005; 77(6):65-8. PubMed ID: 16078604 [TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [TBL] [Abstract][Full Text] [Related]
12. [Correction of primary hemostasis in patients suffering from arterial hypertension with metabolic syndrome]. Medvedev IN Klin Med (Mosk); 2007; 85(3):29-33. PubMed ID: 17523400 [TBL] [Abstract][Full Text] [Related]
13. [Effect of eprosartan on thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome]. Simonenko VB; Medvedev IN; Kumova TA Klin Med (Mosk); 2008; 86(4):19-21. PubMed ID: 18494280 [TBL] [Abstract][Full Text] [Related]
15. ACE inhibitor effects on platelet function in stages I-II hypertension. Moser L; Callahan KS; Cheung AK; Stoddard GJ; Munger MA J Cardiovasc Pharmacol; 1997 Oct; 30(4):461-7. PubMed ID: 9335405 [TBL] [Abstract][Full Text] [Related]
16. Impacts of lisinopril and lisinopril plus simvastatin on erythrocyte and plasma arginase, nitrite, and nitrate in hypertensive patients. Kosenko E; Tikhonova L; Suslikov A; Kaminsky Y J Clin Pharmacol; 2012 Jan; 52(1):102-9. PubMed ID: 21406601 [TBL] [Abstract][Full Text] [Related]
17. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension. Wallis EJ; Ramsay LE; Hettiarachchi J Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801 [TBL] [Abstract][Full Text] [Related]
18. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
19. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Eveson DJ; Robinson TG; Potter JF Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738 [TBL] [Abstract][Full Text] [Related]
20. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Herrera-Arellano A; Miranda-Sánchez J; Avila-Castro P; Herrera-Alvarez S; Jiménez-Ferrer JE; Zamilpa A; Román-Ramos R; Ponce-Monter H; Tortoriello J Planta Med; 2007 Jan; 73(1):6-12. PubMed ID: 17315307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]